# Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

> **NCT00266708** · PHASE1,PHASE2 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 60 (actual)

## Conditions studied

- Renal Transplant Osteodystrophy

## Interventions

- **DRUG:** Risedronate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00266708
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00266708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00266708, "Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00266708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*